Insider Trading & Ownership - SCHEIBLER LUKAS

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for SCHEIBLER LUKAS
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-12-01
Sale
2023-12-05
7:40 pm
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
Chief Research Officer
10,000$60$600,000107,690
(Direct)
View
2023-09-06
Sale
2023-09-07
4:08 pm
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
Chief Research Officer
1,756$43.01$75,52668,299
(Direct)
View
2022-05-27
Sale
2022-05-31
4:30 pm
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
10,000$43$430,00042,233
(Direct)
View
2022-04-05
Sale
2022-04-06
4:10 pm
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
609$60.09$36,593101,624
(Direct)
View
2022-04-04
Sale
2022-04-05
4:08 pm
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
3,504$56.96$199,589102,233
(Direct)
View
2022-04-01
Sale
2022-04-04
5:03 pm
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
11,496$55.05$632,855105,737
(Direct)
View
2022-02-11
Sale
2022-02-14
6:20 pm
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
1,666$46.8$77,96951,513
(Direct)
View
2022-02-10
Sale
2022-02-14
4:15 pm
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
10,000$50$500,000118,179
(Direct)
View
2022-02-08
Sale
2022-02-10
08:32 am
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
10,000$45$450,000128,857
(Direct)
View
2022-01-31
Sale
2022-02-01
5:58 pm
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
1,233$38.47$47,43453,857
(Direct)
View
2021-06-10
Sale
2021-06-11
4:07 pm
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
3,417$60$205,02026,651
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-12-01
Exercise
2023-12-05
7:40 pm
N/A
N/A
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
Chief Research Officer
10,000$13.85107,690
(Direct)
View
2023-12-01
Exercise
2023-12-05
7:40 pm
N/A
2029-02-07
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
Chief Research Officer
10,000$0107,690
(Direct)
View
2023-02-21
Tax Withholding
2023-02-22
06:49 am
N/A
N/A
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
Chief Research Officer
715$58.583,666
(Direct)
View
2023-02-21
Option Award
2023-02-22
06:49 am
N/A
2032-01-20
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
Chief Research Officer
23,909$083,666
(Direct)
View
2023-02-10
Tax Withholding
2023-02-14
4:44 pm
N/A
N/A
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
Chief Research Officer
678$51.2160,472
(Direct)
View
2023-01-27
Tax Withholding
2023-01-30
5:03 pm
N/A
N/A
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
Chief Research Officer
542$52.7761,150
(Direct)
View
2023-01-20
Tax Withholding
2023-01-24
5:22 pm
N/A
N/A
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
Chief Research Officer
2,015$52.0561,692
(Direct)
View
2023-01-12
Option Award
2023-01-17
7:42 pm
N/A
2033-01-11
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
Chief Research Officer
35,472$52.6699,179
(Direct)
View
2023-01-12
Option Award
2023-01-17
7:42 pm
N/A
N/A
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
Chief Research Officer
22,580$099,179
(Direct)
View
2022-04-21
Other
2022-05-31
4:30 pm
N/A
2031-01-27
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
13,125$042,233
(Direct)
View
2022-04-05
Exercise
2022-04-06
4:10 pm
N/A
N/A
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
609$13.85101,624
(Direct)
View
2022-04-05
Exercise
2022-04-06
4:10 pm
N/A
2029-02-07
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
609$0101,624
(Direct)
View
2022-04-04
Exercise
2022-04-05
4:08 pm
N/A
N/A
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
3,504$13.85102,233
(Direct)
View
2022-04-04
Exercise
2022-04-05
4:08 pm
N/A
2029-02-07
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
3,504$0102,233
(Direct)
View
2022-04-01
Exercise
2022-04-04
5:03 pm
N/A
N/A
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
11,496$13.85105,737
(Direct)
View
2022-04-01
Exercise
2022-04-04
5:03 pm
N/A
2029-02-07
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
11,496$0105,737
(Direct)
View
2022-02-14
Exercise
2022-02-15
4:58 pm
N/A
N/A
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
720$26.73186,010
(Direct)
View
2022-02-14
Exercise
2022-02-15
4:58 pm
N/A
2028-04-12
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
720$0186,010
(Direct)
View
2022-02-10
Exercise
2022-02-14
4:15 pm
N/A
N/A
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
10,000$13.85118,179
(Direct)
View
2022-02-10
Exercise
2022-02-14
4:15 pm
N/A
2029-02-07
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
10,000$0118,179
(Direct)
View
2022-02-10
Tax Withholding
2022-02-14
4:15 pm
N/A
N/A
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
678$47.12118,179
(Direct)
View
2022-02-08
Exercise
2022-02-10
08:32 am
N/A
N/A
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
10,000$13.85128,857
(Direct)
View
2022-02-08
Exercise
2022-02-10
08:32 am
N/A
2029-02-07
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
10,000$0128,857
(Direct)
View
2022-01-28
Tax Withholding
2022-02-01
5:58 pm
N/A
N/A
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
642$38.5953,857
(Direct)
View
2022-01-21
Option Award
2022-01-25
4:58 pm
N/A
2032-01-20
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
63,002$092,683
(Direct)
View
2022-01-21
Exercise
2022-01-24
5:26 pm
N/A
N/A
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
3,021$26.73164,178
(Direct)
View
2022-01-21
Exercise
2022-01-24
5:26 pm
N/A
2028-04-12
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
3,021$0164,178
(Direct)
View
2021-02-10
Tax Withholding
2021-02-11
4:18 pm
N/A
N/A
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
680$47.7229,290
(Direct)
View
2021-01-28
Option Award
2021-02-01
4:39 pm
N/A
2031-01-27
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
65,625$086,220
(Direct)
View
2020-12-08
Exercise
2020-12-09
5:34 pm
N/A
N/A
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
7,482$26.73158,113
(Direct)
View
2020-12-08
Exercise
2020-12-09
5:34 pm
N/A
2028-04-12
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
7,482$0158,113
(Direct)
View
2020-02-10
Option Award
2020-02-12
5:13 pm
N/A
2030-02-09
Apellis Pharmaceuticals Inc.APLSSCHEIBLER LUKAS
See Remarks
65,625$068,560
(Direct)
View